They can be induced in tumor tissues through growth factors and cytokines, such as transforming growth factor β (TGF-β), interleukin 10 (IL-10) and vascular endothelial growth factor (VEGF), and inhibit immune responses through various mechanisms [13]. This evidence concerns the gene TGFB1 and neoplasm.